2024 Superconvergence Biorevolution Series: A Blockbuster Gene Therapy?

Back to Fundswire + Follow

Publication date: 19 September 2024

Published by: WisdomTree

Dr Jamie Metzl, with whom we work on our Biorevolution strategy, recently published Superconvergence: How the Genetics, Biotech, and AI Revolutions will Transform our Lives, Work and World. We believe we are on the precipice of a remarkable period in this field, which will evolve how we do things. Here, we discuss the topic of possible blockbuster gene therapies, seen through the lens of a specific approach from Sarepta Pharmaceuticals to treat Duchenne Muscular Dystrophy.

Read more >

Historical performance is not an indication of future results and any investments may go down in value.

 

Article originally published by WisdomTree. FE fundinfo is not responsible for its content or accuracy and may not share the author’s views. News and research are not personal recommendations to deal. All investments can fall in value so you could get back less than you invest.

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

Groups

More Articles

Editor's Picks

Loading...